• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by SRAX Inc.

    2/3/22 4:55:18 PM ET
    $SRAX
    Advertising
    Consumer Discretionary
    Get the next $SRAX alert in real time by email
    SC 13G 1 srax13g-020222.htm
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C.  20549
    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. __ )*
    SRAX, Inc.
    (Name of Issuer)
    Class A common stock, par value $0.001 per share
    (Title of Class of Securities)
    78472M106
    (CUSIP Number)
    January 24, 2022
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [ ]            Rule 13d-1(b)
    [x]            Rule 13d-1(c)
    [ ]            Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    1.
    NAMES OF REPORTING PERSONS
       
     
    Whitefort Capital Master Fund, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [ ]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Cayman Islands
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,713,410
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,713,410
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,713,410
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.6%
       
    12.
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
     
    PN



    1.
    NAMES OF REPORTING PERSONS
       
     
    Whitefort Capital Management, LP
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [ ]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    Delaware
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,713,410
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,713,410
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,713,410
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.6%
       
    12.
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
     
    PN, IA
     
     


    1.
    NAMES OF REPORTING PERSONS
       
     
    David Salanic
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [ ]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    France
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,713,410
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,713,410
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,713,410
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.6%
       
    12.
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
     
    IN, HC
     
     


    1.
    NAMES OF REPORTING PERSONS
       
     
    Joseph Kaplan
       
    2.
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
     
    (a)    [ ]
     
    (b)    [ ]
       
    3.
    SEC USE ONLY
       
    4.
    CITIZENSHIP OR PLACE OF ORGANIZATION
       
     
    United States
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
       
    5.
    SOLE VOTING POWER
       
     
    0
       
    6.
    SHARED VOTING POWER
       
     
    1,713,410
       
    7.
    SOLE DISPOSITIVE POWER
       
     
    0
       
    8.
    SHARED DISPOSITIVE POWER
       
     
    1,713,410
       
    9.
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
     
    1,713,410
       
    10.
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
    EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)   [ ]
       
    11.
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
       
     
    6.6%
       
    12.
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
       
     
    IN, HC


    Item 1(a).
    Name of Issuer:
    SRAX, Inc. (“Issuer”)
    Item 1(b).
    Address of Issuer’s Principal Executive Offices:
    2629 Townsgate Road #215
    Westlake Village, CA 91361
    Item 2(a).
    Name of Persons Filing:
    The names of the persons filing this statement on Schedule 13G are (collectively, the “Reporting Persons”):
    •
    Whitefort Capital Master Fund, LP, a Cayman Islands exempted limited partnership (the “Master Fund”);

    •
    Whitefort Capital Management, LP, a Delaware limited partnership (“Whitefort Management”);

    •
    David Salanic, a French citizen (“Mr. Salanic”); and

    •
    Joseph Kaplan, a United States citizen (“Mr. Kaplan”).

    Whitefort Management acts as the investment manager of the Master Fund. Each of Mr. Salanic and Mr. Kaplan is a Co-Managing Partner of Whitefort Management.
    By virtue of these relationships, each of Whitefort Management, Mr. Salanic and Mr. Kaplan may be deemed to have voting and dispositive power with respect to Class A Shares (as defined below) owned by the Master Fund.
    Item 2(b).
    Address of Principal Business Office or, if None, Residence:
    The principal business address of each of the Reporting Persons is 12 East 49th Street, 40th Floor, New York, New York 10017.
    Item 2(c).
    Citizenship:
    Mr. Salanic is a citizen of France.
    Mr. Kaplan is a citizen of the United States.
    The Master Fund is a limited partnership formed under the laws of the Cayman Islands.
    Whitefort Management is a limited partnership formed under the laws of the State of Delaware.
    Item 2(d).
    Title of Class of Securities:
    Class A common stock, par value $0.001 per share (the “Class A Shares”)
    Item 2(e).
    CUSIP Number:
    78472M106

    Item 3.
    If This Statement is Filed Pursuant to Rule 13d 1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
     
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Exchange Act.
           
     
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Exchange Act.
           
     
    (c)
    [ ]
    Insurance company defined in Section 3(a)(19) of the Exchange Act.
           
     
    (d)
    [ ]
    Investment company registered under Section 8 of the Investment Company Act.
           
     
    (e)
    [ ]
    Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
           
     
    (f)
    [ ]
    Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
           
     
    (g)
    [ ]
    Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
           
     
    (h)
    [ ]
    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
           
     
    (i)
    [ ]
    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
           
     
    (j)
    [ ]
    Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).
           
     
    (k)
    [ ]
    Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4.                          Ownership.
    (a)
    Amount beneficially owned:
    As of the close of business on February 3, 2022,
    (i)
    The Master Fund owned 1,713,410 Class A Shares;

    (ii)
    Whitefort Management, as the investment manager of the Master Fund, may be deemed to beneficially own the 1,713,410 Class A Shares owned by the Master Fund;

    (iii)
    Mr. Salanic, as a Co-Managing Partner of Whitefort Management, may be deemed to beneficially own the 1,713,410 Class A Shares owned the Master Fund.

    (iv)
    Mr. Kaplan, as a Co-Managing Partner of Whitefort Management, may be deemed to beneficially own the 1,713,410 Class A Shares owned by the Master Fund.

    (b)
    Percent of Class:
    The percentage of Class A Shares reported owned by each person named herein is based upon 26,149,032 Class A Shares outstanding as of November 12, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 15, 2021. As of the close of business on February 3, 2022, each of the Reporting Persons may be deemed to beneficially own 6.6% of the outstanding Class A Shares.
    (c)
    Number of shares as to which such person has:

    (i)
    Sole power to vote or to direct the vote:
    See Cover Pages Items 5-8.


    (ii)
    Shared power to vote or to direct the vote:
    See Cover Pages Items 5-8.

    (iii)
    Sole power to dispose or to direct the disposition:
    See Cover Pages Items 5-8.

    (iv)
    Shared power to dispose or to direct the disposition:
    See Cover Pages Items 5-8.
    Item 5.
    Ownership of Five Percent or Less of a Class.
    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
    Not applicable.
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
    Not applicable.
    Item 8.
    Identification and Classification of Members of the Group.
    See Exhibit A.
    Item 9.
    Notice of Dissolution of Group.
    Not applicable.
    Item 10.
    Certification.
    By signing below each of the undersigned certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURES
    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
    Dated: February 3, 2022
    WHITEFORT CAPITAL MASTER FUND, LP
    By: Whitefort Capital GP, LLC, its general partner
     
    By:
    /s/ David Salanic
     
    David Salanic, Co-Managing Partner
         
    By:
    /s/ Joseph Kaplan
     
    Joseph Kaplan, Co-Managing Partner

    WHITEFORT CAPITAL MANAGEMENT, LP
     
    By:
    /s/ David Salanic
     
    David Salanic, Co-Managing Partner
         
    By:
    /s/ Joseph Kaplan
     
    Joseph Kaplan, Co-Managing Partner

    /s/ David Salanic
    DAVID SALANIC

    /s/ Joseph Kaplan
    JOSEPH KAPLAN



    EXHIBIT A
    JOINT FILING AGREEMENT
    The undersigned hereby agree that the statement on Schedule 13G with respect to the Class A Shares, par value $0.001 per share, of SRAX, Inc. dated February 3, 2022 and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
    Dated: February 3, 2022
    WHITEFORT CAPITAL MASTER FUND, LP
    By: Whitefort Capital GP, LLC, its general partner
     
    By:
    /s/ David Salanic
     
    David Salanic, Co-Managing Partner
         
    By:
    /s/ Joseph Kaplan
     
    Joseph Kaplan, Co-Managing Partner

    WHITEFORT CAPITAL MANAGEMENT, LP
     
    By:
    /s/ David Salanic
     
    David Salanic, Co-Managing Partner
         
    By:
    /s/ Joseph Kaplan
     
    Joseph Kaplan, Co-Managing Partner

    /s/ David Salanic
    DAVID SALANIC

    /s/ Joseph Kaplan
    JOSEPH KAPLAN


    Get the next $SRAX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SRAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRAX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • June 7, 2024 - FDA Roundup: June 7, 2024

      For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

      6/7/24 3:46:22 PM ET
      $GERN
      $SRAX
      $SNAP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Advertising
      Consumer Discretionary
    • March 22, 2024 - FDA Roundup: March 22, 2024

      For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

      3/22/24 5:02:42 PM ET
      $SNAP
      $SRAX
      Computer Software: Programming Data Processing
      Technology
      Advertising
      Consumer Discretionary
    • November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

      For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

      11/9/23 2:30:20 PM ET
      $SRAX
      $SNAP
      Advertising
      Consumer Discretionary
      Computer Software: Programming Data Processing
      Technology

    $SRAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Miglino Christopher bought $750 worth of SRAX Common Stock (15,000 units at $0.05), increasing direct ownership by 2% to 902,575 units (SEC Form 4)

      4 - SRAX, Inc. (0001538217) (Issuer)

      12/28/23 5:25:44 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 4 filed by Urban Alan Louis

      4 - SRAX, Inc. (0001538217) (Issuer)

      3/22/23 2:57:48 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 3 filed by new insider Urban Alan Louis

      3 - SRAX, Inc. (0001538217) (Issuer)

      3/22/23 2:56:42 PM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SRAX Signs Agreement to Merge with DNA Holdings

      Westlake Village, CA, May 08, 2024 (GLOBE NEWSWIRE) -- SRAX Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform Sequire, announced today it has entered into a definitive merger agreement with DNA Holdings Venture Inc. pursuant to which the shareholders of DNA will become the majority owners of SRAX's outstanding common stock as more fully described below upon the closing of the merger. DNA has been a long term investor in SRAX and currently owns approximately 35% of the company.  DNA is  a Web3 investment company which provides both advisory services and invests in Web3 infrastructure. The company was foun

      5/8/24 8:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX SELECTS XDEFI AS WEB3 WALLET PARTNER, ENABLING SECURE ACCESS TO DIGITAL ASSETS FOR ACTIVE EQUITY INVESTORS

      Los Angeles, March 05, 2024 (GLOBE NEWSWIRE) -- Los Angeles, [5 March 2024] - SRAX Inc. (OTC:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform Sequire, today announced it has selected XDEFI as its Web3 wallet partner. XDEFI is a pioneering multichain cryptocurrency wallet. The partnership will enable SRAX's network of active equity investors to access decentralized applications and assets spanning 200+ blockchains, seamlessly and securely. In addition, SRAX clients who download the wallet will be eligible for airdrops in $XDEFI tokens and many future token airdrops.  In 2023, over $5 billion was given away through

      3/5/24 8:30:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SRAX SHAREHOLDER LETTER

      Westlake Village, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Dear Shareholders, As I write to you today, I do so with a sense of deep reflection on the year that has passed. It's been a period that tested our resilience. I want to express my sincere regret for the concerns and frustrations you may have experienced as a result of our stock price. Addressing Our Challenges Head-On Our delisting from the NASDAQ market was a moment for serious introspection. Looking back, there were areas where we should have been more proactive, especially as it relates to our accounting team's leadership and the complexities of the accounting for our business.  Bringing in new experts was a turning point for th

      12/18/23 7:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    SEC Filings

    See more
    • SEC Form 10-Q filed by SRAX Inc.

      10-Q - SRAX, Inc. (0001538217) (Filer)

      4/30/25 6:18:31 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 10-Q filed by SRAX Inc.

      10-Q - SRAX, Inc. (0001538217) (Filer)

      3/7/25 6:03:29 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form 10-K filed by SRAX Inc.

      10-K - SRAX, Inc. (0001538217) (Filer)

      9/20/24 5:29:24 PM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    Leadership Updates

    Live Leadership Updates

    See more
    • June 7, 2024 - FDA Roundup: June 7, 2024

      For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

      6/7/24 3:46:22 PM ET
      $GERN
      $SRAX
      $SNAP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Advertising
      Consumer Discretionary
    • SRAX Announces Appointment of New CFO

      Los Angeles, California--(Newsfile Corp. - March 20, 2023) - SRAX, Inc. (NASDAQ:SRAX), a leading financial technology company, has announced the appointment of Alan Urban as the CFO of SRAX. Mr. Urban has over 30 years of experience in corporate finance and accounting. He has previously served in numerous senior management positions, most notably as Chief Financial Officer for ten years at Research Solutions, a provider of SaaS solutions for life science organizations. Mr. Urban also serves on the Board of Directors of GT Biopharma."We are excited to have Alan step into this very important role at SRAX. We believe his 30 years of expertise will be instrumental in getting our accounting t

      3/20/23 9:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • ICOA Inc. Appoints SRAX to Enhance Investor Communications

      LAS VEGAS, NEVADA , April 14, 2022 (GLOBE NEWSWIRE) -- Publicly traded Nevada blockchain, decentralized finance (DeFi), and cryptocurrency-focused investment company ICOA Inc. (OTC:ICOA) announced this week that they have entered a $500,000 deal with SRAX (NASDAQ:SRAX) to maximize and accelerate its communications for interested investors, shareholders, and supporters. Through SRAX, a publicly traded company offering premier operating system tools for publicly traded companies, ICOA will have the ability to further reach its community through sophisticated solutions to assist it in maintaining, communicating, and expanding its shareholder base. With Sequire, a product of SRAX, IC

      4/14/22 9:42:39 AM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

      SC 13G/A - SRAX, Inc. (0001538217) (Subject)

      2/14/24 2:56:29 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

      SC 13G/A - SRAX, Inc. (0001538217) (Subject)

      2/13/24 7:42:04 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

      SC 13G/A - SRAX, Inc. (0001538217) (Subject)

      2/14/23 3:07:08 PM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    Financials

    Live finance-specific insights

    See more
    • SRAX Reassures Investors of Business Health Amid Delisting Notice

      Los Angeles, California--(Newsfile Corp. - March 9, 2023) - SRAX, Inc. (NASDAQ:SRAX), a financial technology company that provides data and insights to publicly traded companies through its SaaS platform Sequire, would like to reassure its investors that the company's core business remains strong despite the recent delisting notice from NASDAQ. The delisting was caused by a late filing, and the company is actively working to regain compliance as soon as possible.We are pleased to report that SRAX has added over 25 new customers in the first quarter of 2023, indicating the strength of our business and the value we provide to our clients. We remain confident that this momentum will continue, a

      3/9/23 9:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • Freedom Holding Acquires LD Micro From SRAX, Inc.

      Purchase brings pre-eminent small-cap platform to the Freedom family Freedom U.S. Markets, LLC, a wholly-owned subsidiary of Freedom Holding Corp. (NASDAQ:FRHC), announced today that it has completed the acquisition of LD Micro from SRAX, Inc. (NASDAQ:SRAX). The total consideration of $8.3 million includes $4 million in cash and FRHC common stock valued at $4.3 million. LD Micro offers two premier small-cap conferences annually, the Invitational: June 6-8 (Los Angeles) and the Main Event: October 3-5 (Los Angeles), which hosts over 200 companies and 1,000 investors. For the past 15 years, the LD Micro conferences have showcased the next big names in the small-cap world to investors and i

      3/6/23 8:00:00 AM ET
      $FRHC
      $SRAX
      Investment Bankers/Brokers/Service
      Finance
      Advertising
      Consumer Discretionary
    • SRAX Acquires DNA Holdings Assets

      Los Angeles, California--(Newsfile Corp. - February 6, 2023) - SRAX, Inc. (NASDAQ:SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has acquired the assets of DNA Holdings, LLC.DNA specializes in helping private technology companies with positioning, marketing, and strategy. The emphasis on private companies provides the expertise for SRAX to accelerate the entrance into the cap table management for private companies. The private cap table management market is anticipated to grow to over $1 Billion by 2030. This market is a natural extension of SRAX's current Sequire Platform that helps public companies m

      2/6/23 8:30:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Dawson James initiated coverage on SRAX with a new price target

      Dawson James initiated coverage of SRAX with a rating of Buy and set a new price target of $10.00

      4/19/21 9:31:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • B. Riley reiterated coverage on SRAX with a new price target

      B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $7.50 from $4.50 previously

      2/12/21 8:22:29 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • Ladenburg Thalmann initiated coverage on SRAX with a new price target

      Ladenburg Thalmann initiated coverage of SRAX with a rating of Buy and set a new price target of $7.00

      2/8/21 7:58:16 AM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $SRAX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Miglino Christopher bought $750 worth of SRAX Common Stock (15,000 units at $0.05), increasing direct ownership by 2% to 902,575 units (SEC Form 4)

      4 - SRAX, Inc. (0001538217) (Issuer)

      12/28/23 5:25:44 PM ET
      $SRAX
      Advertising
      Consumer Discretionary